EmVenio Research offers a network of Community Research Sites (CRS) located in underrepresented communities to better reach difficult-to-reach and diverse patient populations. We currently have 13 sites located throughout the US and 10 sites in the UK with the ability to activate studies in as little as 4 weeks (with a final protocol). EmVenio can also establish CRS in new locations within 12 weeks with client exclusivity allowing clients to conduct a mix of studies within those sites. Combining our CRS locations with our Home & Virtual Visit capabilities further reduces clinical research participation burden to patients, avoiding early termination risk. Presently we are achieving 98.5 % enrollment targets with >50% diverse population enrollment. Visit emvenio.com to learn more.